FDA approves landmark pancreatic cancer drug that's shown to improve survival
The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of cancer.
The Food and Drug Administration has approved a new drug for advanced pancreatic cancer. This approval offers U.S. patients a more effective treatment. Pancreatic cancer is known as one of the deadliest types of cancer.
- The FDA approved a new drug for advanced pancreatic cancer.
- This offers U.S. patients a more effective treatment.
- Pancreatic cancer is one of the deadliest types of cancer.
Write a comment